High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting Enzyme
T. J. Esparza, N. P. Martin, G. P. Anderson, E. R. Goldman, D. L. Brody
This study identifies nanobodies that block SARS-CoV-2 spike protein interaction with ACE2, showing high affinity and stability after nebulization.
bioRxiv · Jul 24, 2020Biochemistry